Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures
Clinical trial NCT05067634 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05067634
- Sponsor
- SK Life Science, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-14
- Primary completion
- 2026-11-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.